A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma
Clinical trial NCT06261957 · COMPLETED
Trial details
- NCT number
- NCT06261957
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-31
- Primary completion
- 2025-09-02
- Enrollment
- 477
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.